Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 14.6B | 14.8B | 13.2B | 16.0B |
Cost of revenue | 12.0B | 12.2B | 10.9B | 13.3B |
Gross profit | 2.5B | 2.5B | 2.3B | 2.7B |
Operating expense | ||||
Research & development | 864.9M | 830.2M | 900.1M | 896.4M |
Selling general and admin | 983.3M | 969.7M | 892.5M | 1.0B |
Other operating expenses | — | — | — | — |
Operating income | 699.5M | 739.1M | 511.9M | 826.1M |
Non operating interest income | ||||
Income | 139.7M | 112.1M | 165.6M | 140.4M |
Expense | 48.0M | 46.3M | 45.7M | 37.8M |
Other income expense | — | — | — | — |
Pretax income | 901.7M | 973.3M | 612.4M | 1.0B |
Tax provision | 168.2M | 233.6M | 120.8M | 208.9M |
Net income | 733.5M | 739.8M | 491.6M | 837.3M |
Basic EPS | 1.6 | 1.6 | — | 1.7 |
Diluted EPS | 1.6 | 1.6 | — | 1.7 |
Basic average shares | 458.4M | 458.4M | — | 454.6M |
Diluted average shares | 464.2M | 463.3M | — | 462.8M |
EBITDA | 1.3B | 1.4B | 1.0B | 1.5B |
Net income from continuing op. | 901.7M | 973.3M | 612.4M | 1.0B |
Minority interests | 0 | 0 | -16.3M | -64.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |